Combining LINE-1 hypomethylation with other epigenetic markers, such as RASSF1A hypermethylation in HCC or AIM1 methylation in melanoma, has further enhanced prognostic accuracy and predicted early recurrence after surgery. This evidence concerns the gene CRYBG1 and hepatocellular carcinoma.